Middle East Pharmaceutical Company Ltd. (4016)
Market Closed
15 Oct, 12:00 PM
XSAU 
JPX Primary XSAU ﷼
62. 40
+0.7
+1.1345%
﷼
- Market Cap
- P/E Ratio
120% Div Yield
44,874 Volume
- Eps
﷼ 61.7
Previous Close Want to track 4016 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Middle East Pharmaceutical Company Ltd. (4016) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.31B
Trailing P/E (ttm) 20.41
Forward P/E -
PEG ratio 1.2
Price/Sales (ttm) 4.32
Price/Book (mrq) 4.99
Enterprise Value/Revenue 4.51
Enterprise Value/EBITDA 16.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 40.89K
Average volume (90 days) 75.34K
Price summary
52-Week low 53.89
52-Week high 79.09
Beta -
50-Day moving average 64.74
200-Day moving average 70.95
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.55
Trailing annual dividend yield 0.0246%
5-Year annual dividend yield -
Payout ratio 0.45
Dividend Date 15 Sep 2026
Ex-Dividend Date 1 Sep 2026
Last split factor 7:4
Last split Date 12 May 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 2.7%
Book value per share (mrq) 12.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
